Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Rituximab on the Development of Anti-Donor Antibodies and Resolution of B Cell Infiltration in the Renal Allograft of Patients Undergoing Rejection

NCT00695097 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT00695097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00695097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Rituximab on the Development of Anti-Donor Antibodies and Resolution of B Cell Infiltration in the Renal Allograft of Patients Undergoing Rejection
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2004
Completion date
December 31, 2010
Enrollment
18 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

renal transplant rejection